We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

At Regeneron, we take this responsibility very seriously and are ... Regeneron uses its media and investor relations website and social media outlets to publish important information about the ...

In Singapore, Dupixent is the first biologic medicine approved to treat these COPD patients. The prevalence of COPD is estimated to be around 6% of the general population [1], and it ranks as a ...

On May 19, 1890, at a lotus village in Nam Dan district, the central province of Nghe An, a boy named Nguyen Sinh Cung was ...

This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.” — Mary ...

Seated from left, Steve Horton, President, Grandview Consulting Group; Mickey Jamal, CEO, Chestnut Market; Christina Chan, ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...